Cibus, Inc. - CBUS STOCK NEWS

Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company, has been named a finalist for the Euroseeds2024 InnovActor Award. The company's technology will be showcased on the InnovAction Stage at the Euroseeds2024 Congress in Copenhagen, Denmark, from October 13-16. Dr. Jim Radtke, SVP of Product Development, will present Cibus' technology. The event focuses on innovations in modern plant breeding, crop resilience, quality improvement, and data-driven decision-making in breeding.

Cibus' RTDS®-based high throughput breeding system is recognized for its potential to transform European agriculture. The technology aims to increase the speed and efficiency of bringing new plant traits to market, addressing challenges in agriculture such as disease resistance, climate change adaptation, nutrient use efficiency, and yield improvement.

Cibus, a leading agricultural technology company (Nasdaq: CBUS), announced its participation in the Food+ Forum during the 79th session of the United Nations General Assembly in New York. Peter Beetham, Co-Founder, President and Chief Operating Officer, will join a panel discussion on 'Sowing Solutions: Innovations in Climate-Resilient Seeds' on September 26, 2024, at 12:50 pm ET.

Beetham emphasized Cibus' role in addressing climate change's impact on global food systems through gene editing technology. The company's RTDS-based high throughput breeding system is developing improved crops that are more adaptive to changing environmental conditions, manage plant diseases, and optimize nutrient usage.

The Food+ Forum, hosted by Foreign Policy Magazine, will bring together experts, scientists, policymakers, investors, and entrepreneurs working on sustainable food systems, crop science, regenerative agriculture, and soil sustainability.

Cibus (Nasdaq: CBUS), a leading agricultural biotechnology company, has announced the pricing of its public offering of 3,000,000 shares of Class A Common Stock at $4.00 per share. The company expects to raise approximately $12.0 million in gross proceeds before deducting underwriting discounts and expenses. Cibus has granted underwriters a 45-day option to purchase an additional 450,000 shares to cover over-allotments.

The offering is set to close on September 19, 2024. Cibus plans to use the net proceeds to fund the development of new seed traits, improve existing ones, support Trait Machine operations, and for working capital and general corporate purposes. Roth Capital Partners and A.G.P./Alliance Global Partners are acting as joint book-running managers for the offering.

Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company, has announced a proposed public offering of its Class A common stock. The company plans to grant underwriters a 45-day option to purchase up to an additional 15% of the offered shares. Roth Capital Partners and A.G.P./Alliance Global Partners are acting as joint bookrunning managers for the offering. Cibus intends to use the net proceeds to fund the development of new seed traits, improve existing ones, support Trait Machine operations, and for working capital. The offering is subject to market conditions, and there is no guarantee of its completion or terms. Some existing investors and the CEO have shown interest in purchasing shares, but this is not binding.

Cibus (Nasdaq: CBUS) has completed initial field tests of its Pod Shatter Reduction (PSR) trait in winter oilseed rape in the UK, marking the first gene-edited trait to complete such trials in the country. The promising results support Cibus' ongoing commercial development of the PSR trait. This milestone was made possible by simplified UK regulations introduced in 2022, allowing for science-based testing of gene-edited traits.

Cibus utilizes its proprietary Rapid Trait Development System™ (RTDS®) to develop complex gene-edited traits. The PSR trait aims to address potential yield losses of 5% to 25% due to pod shatter in winter oilseed rape. The successful trials pave the way for a second season of testing, with Cibus looking to deliver the benefits of precision breeding to UK farmers and the broader European agricultural community.

Cibus (Nasdaq: CBUS), a leading agricultural technology company, has announced its participation in two major investor events in August 2024. The company, which develops plant traits for licensing to seed companies, will be represented by Co-Founders Rory Riggs (CEO and Chairman) and Peter Beetham (President and COO) at both events.

The first event is the Canaccord Genuity 44th Annual Growth Conference in Boston, MA, on August 13-14. Riggs and Beetham will present on August 14 at 12:30 p.m. ET. The second event is the Sidoti Micro Cap Conference, a virtual event on August 14-15. Here, they will meet with investors and give a presentation on August 14 at 3:15 p.m. ET. Both presentations will be accessible via live audio webcasts, with links provided for interested parties to join.

Cibus Inc. (NASDAQ: CBUS) reported its Q2 2024 financial results and provided a business update. Key highlights include:

1. Secured an agreement for Herbicide Tolerance traits in Rice with FEDEARROZ, marking the fourth customer in this segment.

2. Successfully completed edits for a third mode of action in Sclerotinia resistance and initial edits for Nutrient Use Efficiency trait in Canola.

3. Operationalized the Wheat platform, enabling access to the largest global grain crop.

4. Expanded IP coverage across 10 plant trait and editing families.

5. Q2 2024 financial results: R&D expense $13.0M, SG&A expense $9.3M, Net loss $28.5M, Cash position $30.0M as of June 30, 2024.

6. Expects current cash to fund operations into Q4 2024.

Cibus (Nasdaq: CBUS) has announced positive initial field trial results for a novel weed management solution in rice using stacked gene edited herbicide tolerant traits. The trials showed that using two herbicides provided excellent weed control. This approach could enable farmers to use a comprehensive weed management system with two different modes of action, potentially reducing the risk of resistant weeds.

The company believes stacked traits are important for modernizing crop breeding, allowing for more efficient development of complex traits to address major farming yield constraints. Cibus is using its Rapid Trait Development System (RTDS®), including Gene Repair Oligonucleotides (GRON) and molecular scissors like TALENs, to develop these traits.

Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company, has announced it will report its second quarter 2024 financial results on Thursday, August 8, 2024, after market close. The company will host a conference call and audio webcast at 4:30 p.m. ET to discuss the financial results and provide company updates.

Interested parties can join the call using the following numbers: +1-800-343-5172 (U.S.) or +1-203-518-9856 (International), with the conference ID 'CIBUS' or 24287. A replay will be available until August 22, 2024. The live audio webcast and accompanying slides will be accessible on the company's investor website, with an archived version available for 90 days post-event.